Annual report [Section 13 and 15(d), not S-K Item 405]

INCOME TAXES - Deferred tax asset (Details)

v3.25.4
INCOME TAXES - Deferred tax asset (Details) - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Deferred tax assets    
Net operating loss carry forwards $ 10,470,168 $ 8,017,189
Share-based compensation 4,564,063 4,054,969
Research and development credit carryforwards 331,671 331,671
Capitalized research and development 3,379,658 3,752,043
Other 41,905 154,625
Gross deferred tax assets 18,787,465 16,310,497
Less valuation allowance (18,787,465) (16,310,497)
Capitalized research and development $ 2,200,000 $ 5,700,000